The triumph of the Oxford-AstraZeneca vaccine
Despite setbacks, the jab has probably saved more lives than any other
IN A SOLEMN pre-recorded address, Boris Johnson warned Britons that a “tidal wave” of Omicron was on its way, and that the best chance of escape lay in booster vaccines. All adults, the prime minister announced on December 12th, would be offered one by the end of 2021. Yet their choice is to be more limited than in the last vaccination push, with Moderna and Pfizer leading the way. Nearly a year after it was first approved, Britain’s flagship Oxford-AstraZeneca jab will be rarely used.
This article appeared in the Britain section of the print edition under the headline "A dose for the world"
From the December 16th 2021 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Britain
Why so many Britons have taken to stand-up paddleboarding
It combines fitness, wellness and smugness
Why Britain’s membership of the ECHR has become a political issue
And why leaving would be a mistake
The ECtHR’s Swiss climate ruling: overreach or appropriate?
A ruling on behalf of pensioners does not mean the court has gone rogue